Resources

Type of publications
Regions
Diseases

5192 results found

2021 ∙ Commission Technique des Vaccinations, Haute Autorité de Santé

Vaccination strategy against Covid-19 - AstraZeneca vaccine

  • Recommendation
  • Europe
  • France
  • AstraZeneca COVID-19 vaccine
  • COVID-19
Download:
2021 ∙ Haute Autorité de Santé

Vaccination strategy against Covid-19 - Janssen COVID-19 vaccine

  • Recommendation
  • Europe
  • France
  • Janssen COVID-19 Vaccine
  • COVID-19
Download:
2021 ∙ Commission Technique des Vaccinations, Haute Autorité de Santé

Vaccination strategy against Covid-19 - the Moderna Covid-19 mRNA (nucleoside modified) vaccine

  • Recommendation
  • Europe
  • France
  • Moderna COVID-19 vaccine
  • COVID-19
Download:
2021

Vaccination strategy against COVID19 in Spain

  • Recommendation
  • Europe
  • Spain
  • booster dose
  • Pfizer-BioNTech vaccine
  • Moderna COVID-19 vaccine
  • Janssen COVID-19 Vaccine
  • COVID-19
Download:
2021 ∙ SAGE

WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply - 16 July 2021

  • Position paper
  • Priority Groups
  • COVID-19
Download:
2020 ∙ Corder, B. N. Bullard, B. L. Poland, G. A. Weaver, E. A.

A decade in review: A systematic review of universal influenza vaccines in clinical trials during the 2010 decade

  • All age groups
  • Influenza
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Not applicable
2020 ∙ Gou, X. Wu, X. Shi, Y. Zhang, K. Huang, J.

A systematic review and meta-analysis of cross-reactivity of antibodies induced by H7 influenza vaccine

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2020 ∙ Sideris, A. Holmes, T. R. Cumming, B. Havas, T.

A systematic review and meta-analysis of predictors of airway intervention in adult epiglottitis

  • Adolescents
  • Adults
  • Older adults
  • Haemophilus influenzae type B
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2020 ∙ Mavundza, E. J. Wiyeh, A. B. Mahasha, P. W. Halle-Ekane, G. Wiysonge, C. S.

A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2020 ∙ Vu, M. Berg, C. J. Escoffery, C. Jang, H. M. Nguyen, T. T. Travis, L. Bednarczyk, R. A.

A systematic review of practice-, provider-, and patient-level determinants impacting Asian-Americans’ human papillomavirus vaccine intention and uptake

  • Americas
  • United States of America
  • Adolescents
  • Adults
  • Parents/caregivers
  • Healthcare workers
  • Human papillomavirus (HPV)
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
Loading...